Cargando…
Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies
T cell immune protection plays a pivotal role in the treatment of patients with hematological malignancies. However, T cell exhaustion might lead to the possibility of immune escape of hematological malignancies. Adoptive cell therapy (ACT) with chimeric antigen receptor T (CAR-T) cells can restore...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547336/ https://www.ncbi.nlm.nih.gov/pubmed/33062678 http://dx.doi.org/10.1155/2020/4241864 |